H.R. 1396 · 119th Congress (2025–2027)
PILLS Act
To amend the Internal Revenue Code of 1986 to establish the generic drugs and biosimilars production credit, and for other purposes.
CRS summary not yet available.
Referred to committee
Latest actionReferred to committee
This bill’s path
This is H.R. 1396’s recorded path, not a universal congressional workflow.
How bills become lawAll actionsIntroduced
Passed House
Passed Senate
Sent to President
Signed into law
- Sponsor
- Rep. Claudia Tenney (R-NY-24)
- Cosponsors
2 cosponsors
0 original · 2 later
- Rep. Nicole Malliotakis (R-NY-11)· Later · Sep 26, 2025
- Rep. W. Gregory Steube (R-FL-17)· Later · Nov 20, 2025
- Policy area
- Taxation
On this page
Timeline
i
In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.
Introduced in House
Document: Introduced in House
Sources
- Congress.gov actionIntro-H
- Library of Congress
- Latest
Referred to committee
Referred to the House Committee on Ways and Means.
Sources
- Congress.gov action
- House floor actions
Committees
Text & titles
i
Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.
| Version | Date | Links |
|---|---|---|
| Introduced in House |
Titles (3)
PILLS Act
Display title, Short title · Introduced in House
Producing Incentives for Long-term production of Lifesaving Supply of medicine Act
Short title · Introduced in House
To amend the Internal Revenue Code of 1986 to establish the generic drugs and biosimilars production credit, and for other purposes.
Official title · Introduced in House